Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fellermann

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pathology|April 30, 2003
Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori statusJ Wehkamp, K Schmidt, K R Herrlinger, et al.
Journal of Crohn'S & Colitis|October 1, 2015
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine AnaloguesK J Schmidt, N Müller, A Dignass, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2010
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimusK R Herrlinger, D N Barthel, K J Schmidt, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2012
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patientsK J Schmidt, K R Herrlinger, J Emmrich, et al.
Alimentary Pharmacology & Therapeutics|June 25, 2009
Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's diseaseI Kübler, M J Koslowski, M Gersemann, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 7, 2015
Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter StudyT Bernatik, A Schuler, G Kunze, et al.
Digestive Diseases and Sciences|June 18, 2002
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensinsJ Wehkamp, B Schwind, K R Herrlinger, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
6-thioguanine--efficacy and safety in chronic active Crohn's diseaseK R Herrlinger, W Kreisel, M Schwab, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2004
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's diseaseK R Herrlinger, K Fellermann, C Fischer, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2017
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitisF Bär, T Kühbacher, N A Dietrich, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|April 30, 2003
Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori statusJ Wehkamp, K Schmidt, K R Herrlinger, et al.
Journal of Crohn'S & Colitis|October 1, 2015
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine AnaloguesK J Schmidt, N Müller, A Dignass, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2010
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimusK R Herrlinger, D N Barthel, K J Schmidt, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2012
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patientsK J Schmidt, K R Herrlinger, J Emmrich, et al.
Alimentary Pharmacology & Therapeutics|June 25, 2009
Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's diseaseI Kübler, M J Koslowski, M Gersemann, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 7, 2015
Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter StudyT Bernatik, A Schuler, G Kunze, et al.
Digestive Diseases and Sciences|June 18, 2002
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensinsJ Wehkamp, B Schwind, K R Herrlinger, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
6-thioguanine--efficacy and safety in chronic active Crohn's diseaseK R Herrlinger, W Kreisel, M Schwab, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2004
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's diseaseK R Herrlinger, K Fellermann, C Fischer, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2017
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitisF Bär, T Kühbacher, N A Dietrich, et al.
Pageof 5